[Asia Economy Reporter Park Jun-yi] Access Bio announced on the 23rd that it has decided to purchase automated production equipment worth 15.4 billion KRW to expand its rapid diagnostic kit production capacity. The investment amount is equivalent to 55.20% of the company's equity capital based on last year's consolidated financial statements.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing